Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer (2019) Fietkau R, Hecht M, Hofner B, Iro H, Gefeller O, Roedel C, Hautmann M, et al. Conference contribution QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04) (2019) Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, et al. Conference contribution Neutrophilia as prognostic factor for outcome in the CAO/ARO/ALO-04 phase 3 rectal cancer trial (2019) Diefenhardt M, Hofheinz R, Beissbarth T, Arnold D, Von Den Gruen JM, Liersch T, Stroebel P, et al. Conference contribution Error detection using an electromagnetic tracking system in multicatheter interstitial brachytherapy (2019) Masitho S, Kallis K, Strnad V, Fietkau R, Bert C Conference contribution Variability in catheter reconstruction for multi-catheter interstitial brachytherapy (2019) Kallis K, Kaltsas T, Kreppner S, Lotter M, Strnad V, Fietkau R, Bert C Conference contribution Automated data processing and BigData in radiation therapy (2019) Schmidt O, Ballmann N, Bert C, Fietkau R Conference contribution Performance of Marker-less Tracking for Gimbaled Dynamic Tumor Tracking (2019) Ziegler M, Lettmaier S, Fietkau R, Bert C Conference contribution Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: A case report (2019) Semrau S, Agaimy A, Pavel ME, Lubgan D, Schmidt D, Golcher H, Grützmann R, et al. Journal article